U.S. Retail REITs Stock News

ANI Pharmaceuticals has delivered a strong 139.1% return over the past 5 years, yet at around US$79.20 the valuation checks now suggest the stock is closer to fairly priced than obviously cheap. A 139.1% total return over 5 years indicates ANI Pharmaceuticals has already rewarded patient shareholders, so fresh buyers may be weighing how much of the story is reflected in the current price. Positive topline data from the SYNCHRONICITY trial can support expectations for the branded portfolio,...

Bell Canada has completed its first direct to device satellite ground station to support AST SpaceMobile's network in Canada. AST SpaceMobile secured new regulatory approval in New Zealand, expanding its potential service footprint. The company is preparing for the launch of additional BlueBird satellites to build out its direct to device constellation. AST SpaceMobile (NasdaqGS:ASTS) is back in focus as it adds fresh infrastructure and regulatory pieces to its direct to device puzzle. The...

Geopolitics just moved back to the front of the market’s attention, with U.S. strikes on Iran, drone and missile attacks across the Gulf, and oil prices reacting sharply. When tensions spill into shipping lanes and supply chains, some stocks can gain new contracts or attention, while others face higher risks and costs. This article looks at how that mix of risk and opportunity connects to the latest Defense and Aerospace Stocks screener and highlights 3 stocks that appear positively exposed...

Abbott Laboratories (ABT) just posted Q2 2026 revenue of about US$12.6b with basic EPS of US$0.53, alongside trailing twelve month revenue of roughly US$46.6b and EPS of US$3.11. Over recent quarters the company has seen revenue move from about US$11.1b in Q2 2025 to US$12.6b in Q2 2026, while quarterly EPS shifted from US$1.02 to US$0.53. This sets up a results season where investors are likely to focus closely on how margins are holding up in the current mix of growth drivers. See our full...

EchoStar CEO Hamid Akhavan has resigned, with leadership duties moving to Charles W. Ergen and Thomas A. Cullen. The change comes alongside a shift in EchoStar's strategic direction affecting how key business units are run. Investors are assessing what the new leadership structure could mean for culture, execution, and the company’s future focus. EchoStar, traded as NasdaqGS:ECHO, is entering a transition period at a time when its share price sits at $92.0. The stock is down 4.2% over the...

Intuitive Surgical (ISRG) has released its Q2 2026 numbers, with revenue of US$2.9 billion and basic EPS of US$2.31, set against trailing 12 month revenue of US$11.0 billion and EPS of US$8.84. Over recent quarters, the company has seen revenue move from US$2.44 billion in Q2 2025 to US$2.89 billion in Q2 2026, while quarterly EPS shifted from US$1.84 to US$2.31, with trailing earnings up 20.4% over the past year and 16.7% per year over the past five years. With a net profit margin of 28.4%...

Federal Agricultural Mortgage stock has delivered strong long term gains for shareholders over the past five years, yet the latest valuation work suggests the current share price may still sit below an intrinsic value estimate based on the Excess Returns model. At the same time, traditional earnings multiples look roughly in line with peers, which raises the question of whether the recent share price level around US$205.50 already reflects most of the good news. Federal Agricultural Mortgage...

Primoris Services has delivered a strong 210.3% total return over the past five years, yet its current valuation screens as cheap, with both a Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples suggesting the stock trades at a discount to what the business may be worth. Over five years, Primoris Services has returned 210.3%, which puts recent share price weakness in the context of a strong longer term run. Recent coverage highlighting revenue growth, backlog expansion...

Dana Inc. (NYSE:DAN) announced it will acquire Eaton's Mobility Group through a Reverse Morris Trust transaction. The deal involves creating a new entity that will merge with Dana, with the transaction supported by bridge financing. The acquisition is positioned to increase Dana's margins and aftermarket exposure, affecting its long-term business mix. Dana is a global supplier of power conveyance and energy management solutions for vehicles and machinery. The planned Eaton Mobility Group...

In recent weeks, CarMax reported quarterly earnings that exceeded analyst expectations, with higher-than-forecast revenue supported by robust wholesale vehicle sales despite retail pressures. At the same time, law firm Bernstein Liebhard LLP began investigating potential fiduciary duty breaches by certain CarMax directors and officers affecting shareholders who bought before June 20, 2025, adding a governance angle to the company’s improving operational story. With CarMax’s earnings beat...

American Assets Trust stock has climbed over the last few years and recently touched a new 52 week high, yet its valuation checks and market multiples suggest the shares may no longer be an obvious bargain, even though the Discounted Cash Flow (DCF) estimate points to a roughly fair price relative to the current level. Over the past 3 years, American Assets Trust has returned 39.7%, which puts recent valuation questions front and center after a solid run. Investor sentiment has been...

Dollar General stock has delivered a steep 40.3% decline over the past 5 years, yet current valuation checks and intrinsic value work both suggest the shares now trade at a discount to what the underlying business may be worth. Over 5 years, Dollar General shareholders are down 40.3%, which sets expectations for a potential reset in how the stock is priced relative to its fundamentals. Rising gas prices and household cost pressures can support revenue as consumers trade down to discount...

Partner trial for Darzalex Faspro using Halozyme's ENHANZE technology reported significant survival benefits for multiple myeloma patients. Late stage study results point to improved outcomes for people receiving this subcutaneous therapy. News is material for Halozyme Therapeutics (NasdaqGS:HALO) as it relates directly to one of its key partnered medicines. Halozyme Therapeutics centers its business on ENHANZE, a drug delivery technology licensed to large biopharma partners. The latest...

Visteon (NasdaqGS:VC) has entered new multi year partnership agreements to secure advanced memory and storage supplies for automotive applications. The company is part of Micron's newly completed Strategic Customer Agreements alongside other major automotive suppliers and partners. The partnerships focus on long term supply and technology planning for next generation, AI enabled vehicle platforms. Visteon sits at the intersection of automotive electronics and software, supplying cockpit...

Greenbrier Companies stock has delivered a 37.0% total return over the past 5 years, yet the latest valuation checks point to a mixed picture rather than a clear bargain or clear premium at the current US$50.02 share price. Over 5 years, a 37.0% return suggests Greenbrier Companies has rewarded patient shareholders, which naturally raises the bar for fresh upside from here. Future demand for railcars and related services can support earnings and cash flow, while any pressure on manufacturing...

ACI Worldwide stock has surged over the past three years, yet the valuation picture is mixed, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model suggesting the shares trade below that estimate while the broader checks still do not flag the stock as a clear bargain. ACI Worldwide has returned 150.3% over the past three years, which puts extra focus on whether the current price still leaves room above intrinsic value or mainly reflects past gains. Recent news...

After a very strong three year share price run of 277.6%, Bank of New York Mellon Corporation now faces a valuation debate, with its intrinsic value estimate from the Excess Returns model pointing to the stock trading at a premium, while market multiples suggest pricing that is closer to about right. BNY has delivered a very large 277.6% total return over three years, which means a lot of optimism is already reflected in the share price. Recent earnings momentum, supported by fees, interest...

Peoples Bancorp stock has delivered a 77.3% return over the past 5 years. At a last close of US$39.39, the Excess Returns intrinsic value estimate still points to meaningful upside, while the market multiples suggest the shares are priced roughly in line with peers. Over 5 years, a 77.3% total return suggests the market has already repriced Peoples Bancorp materially higher, so the easy gains may be behind it. Future profitability and loan growth can support the current valuation, but...

Prologis (PLD) kicked off its Q2 2026 update with revenue of about US$2.4 billion and basic EPS of roughly US$1.11 for the quarter, alongside trailing twelve month earnings growth of 22.1% and a net margin of 43.8%. Over the past six quarters, the company has seen revenue move from about US$2.21 billion in Q1 2025 to roughly US$2.43 billion in Q2 2026, with trailing twelve month revenue reaching about US$9.6 billion and basic EPS of around US$4.52. For investors, the combination of higher...

Texas Capital Bancshares has delivered a 68.2% return over the past five years, yet the current valuation picture is mixed, with the Excess Returns intrinsic value estimate indicating the stock may trade below its estimated worth while market multiples sit closer to about right. A 68.2% return over five years points to a stock that has already rewarded patient shareholders, so the question is how much valuation upside may still be on the table. The appointment of Mo Jamous as Chief Digital...

Mattel stock has had a tough run over the past three years, yet its current valuation checks lean cheap, which sets up a clear tension between weak long term returns and a market price that screens as potentially modestly undervalued. Mattel has declined 32.5% over the past three years, which means today’s valuation is being judged against a share price that has already come down meaningfully. On the upside, UBS has highlighted Mattel’s broad brand portfolio as a source of brand equity that...

Ecolab stock has delivered a 48.8% total return over the past three years, and at around US$272.83 per share the key question is whether that run now leaves it trading close to its intrinsic value or at a premium. The Discounted Cash Flow (DCF) estimate points to Ecolab being roughly fairly valued, while the broader valuation checks and market multiples lean more cautious. Ecolab's 48.8% return over three years means anyone who stayed invested has been rewarded, so fresh buyers now need to...

Resideo Technologies has nearly doubled investors' money over the past three years, and the current valuation checks suggest the stock still trades at a discount, with the Discounted Cash Flow (DCF) intrinsic value estimate indicating room above the recent US$35.83 share price. Resideo Technologies has returned 98.4% over the past three years, which puts extra focus on whether that gain is fully backed by fundamentals. The planned spin off of the ADI Global Distribution business may support...

Ameris Bancorp (ABCB) heads into its next earnings report on July 23 with expectations for higher year over year earnings and revenue, putting fresh attention on how the stock prices in those forecasts. See our latest analysis for Ameris Bancorp. The recent 7 day share price return of 2.10% and 30 day share price return of 7.32% suggest momentum has been building in Ameris Bancorp ahead of its earnings update. At the same time, the 1 year total shareholder return of 38.48% and 3 year total...